(Q46650148)

23 December 2017

title

Hypogonadism, quadriceps weakness, and exercise intolerance in chronic obstructive pulmonary disease (English)

1 reference

23 December 2017

chronic obstructive pulmonary disease

1 reference

1 reference

8

Marc Decramer

1 reference

23 December 2017

2

Martijn A Spruit

1 reference

23 December 2017

Roger Bouillon

7

Roger Bouillon

1 reference

23 December 2017

Ahmad Kasran

4

Ahmad Kasran

1 reference

23 December 2017

Monique Van Vliet

1

Monique Van Vliet

1 reference

23 December 2017

Geert M Verleden

3

Geert Verleden

1 reference

23 December 2017

author name string

Erik Van Herck

5

1 reference

23 December 2017

Fabio Pitta

6

1 reference

23 December 2017

language of work or name

English

0 references

publication date

11 August 2005

1 reference

23 December 2017

American Journal of Respiratory and Critical Care Medicine

published in

1 reference

23 December 2017

volume

172

1 reference

23 December 2017

issue

9

1 reference

23 December 2017

page(s)

1105-1111

1 reference

23 December 2017

Characteristics of physical activities in daily life in chronic obstructive pulmonary disease

cites work

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200501-114OC

Peripheral muscle weakness in patients with chronic obstructive pulmonary disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200501-114OC

Comparison of effects of strength and endurance training in patients with chronic obstructive pulmonary disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200501-114OC

Resistance versus endurance training in patients with COPD and peripheral muscle weakness.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200501-114OC

Exercise training during rehabilitation of patients with COPD: a current perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200501-114OC

Short- and long-term effects of outpatient rehabilitation in patients with chronic obstructive pulmonary disease: a randomized trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200501-114OC

Pulmonary rehabilitation in chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200501-114OC

Peripheral muscle strength training in bed-bound patients with COPD receiving mechanical ventilation: effect of electrical stimulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200501-114OC

Peripheral muscle wasting in chronic obstructive pulmonary disease. Clinical relevance and mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200501-114OC

Muscle force during an acute exacerbation in hospitalised patients with COPD and its relationship with CXCL8 and IGF-I.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200501-114OC

Testosterone action on skeletal muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200501-114OC

Older men are as responsive as young men to the anabolic effects of graded doses of testosterone on the skeletal muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200501-114OC

Respiratory and skeletal muscles in hypogonadal men with chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200501-114OC

Effects of testosterone and resistance training in men with chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200501-114OC

Catabolic/anabolic balance and muscle wasting in patients with COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200501-114OC

Testosterone levels in men with chronic obstructive pulmonary disease with or without glucocorticoid therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200501-114OC

Hypothalamic-pituitary dysfunction in respiratory hypoxia

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200501-114OC

Hypogonadism in men with chronic obstructive pulmonary disease: prevalence and quality of life

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200501-114OC

Skeletal muscle weakness in patients with sarcoidosis and its relationship with exercise intolerance and reduced health status

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200501-114OC

A new method of classifying prognostic comorbidity in longitudinal studies: development and validation

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200501-114OC

Muscle strength after resistance training is inversely correlated with baseline levels of soluble tumor necrosis factor receptors in the oldest old.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200501-114OC

Age, Disease, and Changing Sex Hormone Levels in Middle-Aged Men: Results of the Massachusetts Male Aging Study*

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200501-114OC

Racial/ethnic variations in male testosterone levels: a probable contributor to group differences in health.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200501-114OC

Five-day pulsatile gonadotropin-releasing hormone administration unveils combined hypothalamic-pituitary-gonadal defects underlying profound hypoandrogenism in men with prolonged critical illness

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200501-114OC

Episodic luteinizing hormone (LH) secretion and the response of LH and follicle-stimulating hormone to LH-releasing hormone in aged men: evidence for coexistent primary testicular insufficiency and an impairment in gonadotropin secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200501-114OC

Longitudinal changes in testosterone, luteinizing hormone, and follicle-stimulating hormone in healthy older men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200501-114OC

Neuroendocrine regulation of pulsatile luteinizing hormone secretion in elderly men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200501-114OC

Influence of age on the responsiveness of the gonadotrophs to luteinizing hormone-releasing hormone in males

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200501-114OC

Endogenous sex hormones in men aged 40-80 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200501-114OC

Pulmonary function tests and thyroid hormone concentrations in patients with chronic obstructive pulmonary disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200501-114OC

Ageing of the hypothalamo-pituitary-testicular axis in men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200501-114OC

Atrophy of Leydig cells in the testes of men with longstanding chronic bronchitis and emphysema

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200501-114OC

Angiotensin converting enzyme genotype and strength in chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200501-114OC

Clinical review 171: The rationale, efficacy and safety of androgen therapy in older men: future research and current practice recommendations

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200501-114OC

Oral testosterone supplementation increases muscle and decreases fat mass in healthy elderly males with low-normal gonadal status

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200501-114OC

Management of severe COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200501-114OC

Peripheral muscle endurance and the oxidative profile of the quadriceps in patients with COPD

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200501-114OC

Exercise-induced quadriceps oxidative stress and peripheral muscle dysfunction in patients with chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200501-114OC

Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200501-114OC

Acute effect of oral steroids on muscle function in chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200501-114OC

What's wrong with Bonferroni adjustments

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200501-114OC

Elevated plasma ghrelin level in underweight patients with chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200501-114OC

Functional and histologic picture of steroid-induced myopathy in chronic obstructive pulmonary disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200501-114OC

Symptoms and quadriceps fatigability after walking and cycling in chronic obstructive pulmonary disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200501-114OC

Contractile leg fatigue after cycle exercise: a factor limiting exercise in patients with chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200501-114OC

Sexuality in chronic respiratory failure: coincidences and divergences between patient and primary caregiver.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200501-114OC

Testosterone treatment improves body composition and sexual function in men with COPD, in a 6-month randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200501-114OC

Associated loss of fat-free mass and bone mineral density in chronic obstructive pulmonary disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200501-114OC

Sex hormone-binding globulin, estradiol, and bone turnover markers in male osteoporosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200501-114OC

10.1164/RCCM.200501-114OC

21 January 2018

Identifiers

DOI

1 reference

23 December 2017

1 reference

23 December 2017